image

Key updates

What's new on Wikilite
Section Contents
  • What's new on Wikilite
    • Key updates


Date Publication Update
24/02/2017
Tacchetti 2016 [938]Section 20.3.3. Prognostic implications of relapse with FLCs
24/02/2017
Sarto 2016 [936]Section 11.5.1. Comparison of Hevylite and total immunoglobulin measurements
Section 11.5.2. Comparison of Hevylite and immmunoglobulin measurements by SPE
24/02/2017
Murata 2016 [937]Section 18.3.5. Monitoring patients treated with monoclonal antibody-based therapies
21/12/2016
Voortman 2016 [934]Section 36.2. CSF FLCs as a marker of intrathecal immunoglobulin synthesis
Section 36.3. Prognostic significance of CSF FLCs
21/12/2016
Zeman 2016 [933]Section 36.2. CSF FLCs as a marker of intrathecal immunoglobulin synthesis
21/12/2016
Dobson 2013 [935]Section 36.3. Prognostic significance of CSF FLCs
16/10/2016
Dejoie 2016 [914]Section 15.1. Diagnosis of Light chain multiple myeloma
*NEW* Figure 15.4. Sensitivity of serum and urine FLC measurements.
Section 15.2. Monitoring light chain multiple myeloma
Section 20.3.1. Normalisation of the sFLC ratio and importance of a sCR
Section 20.3.2. Early sFLC response predicts outcome
Section 24.8. Comparison of sFLCs and urinalysis for monitoring patients
*NEW* Figure 24.7. Survival outcomes according to serum and urine FLC characteristics at end of induction therapy.
*NEW* Figure 24.8. Abnormal sFLC measurements stratify patients with normal urine results after induction.

Figures